Internal Medicine · Phoenix, AZ
NPI
1821054081
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1441 N 12th St
Phoenix, AZ, 85006
Phone (602) 521-5800
Groups this clinician bills Medicare through
Medicare paid, 2024
$51K
503 services
Medicare patients, 2024
167
Average age 69
Drug cost, 2024
$1.2M
2,441 prescriptions
Company payments, 2025
$6,066
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark Wong was code 99233 (hospital e&m - subsequent), 176 times for 21 patients. In total Mark Wong billed 503 services in 10 codes, and Medicare paid $51K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 176 | 21 | $92.45 | $16K |
| 99215 Office E&M - Established | Facility | 163 | 105 | $106.04 | $17K |
| 99215 Office E&M - Established | Office | 79 | 49 | $115.31 | $9,110 |
| 99214 Office E&M - Established | Facility | 28 | 25 | $73.26 | $2,051 |
| 99223 Hospital E&M - Initial | Facility | 16 | 13 | $126.15 | $2,018 |
By year: 2022 $25K for 284 services; 2023 $33K for 342 services; 2024 $51K for 503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark Wong prescribed most often to Medicare patients was Tacrolimus, with 311 prescriptions and refills. In total Mark Wong wrote 2,441 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 311 | 505 | 73 | $22K |
| Mycophenolate Mofetil Generic | 289 | 476 | 65 | $27K |
| Ursodiol Generic | 240 | 405 | 56 | $83K |
| Vemlidy Tenofovir Alafenamide | 120 | 128 | 12 | $191K |
| Fluconazole Generic | 81 | 115 | 26 | $3,285 |
| Prednisone Generic | 74 | 106 | 34 | $623 |
| Entecavir Generic | 74 | 94 | 14 | $9,666 |
| Carvedilol Generic | 56 | 109 | 16 | $522 |
| Sirolimus Generic | 50 | 76 | Under 11 | $11K |
| Amlodipine Besylate Generic | 49 | 99 | 16 | $363 |
| Pantoprazole Sodium Generic | 46 | 106 | 18 | $493 |
| Famotidine Generic | 42 | 80 | 16 | $532 |
| Spironolactone Generic | 41 | 92 | 16 | $269 |
| Xifaxan Rifaximin | 41 | 49 | Under 11 | $172K |
| Furosemide Generic | 40 | 97 | 14 | $163 |
Brand drugs: - claims; generic drugs: 2,091 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark Wong $6,066 ($6,066 in general payments such as food, travel and fees) from 4 companies. The largest payer was Gilead Sciences, Inc. with $4,796.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.